Citi Upgrades Warby Parker(WRBY.US) to Hold Rating, Cuts Target Price to $17

Moomoo News14:31 ET

Citigroup Upgrades Warby Parker to Neutral, Lowers Price Target to $17

BenzingaApr 30 07:18 ET

BTIG Maintains Warby Parker(WRBY.US) With Buy Rating, Cuts Target Price to $24

Moomoo NewsApr 29 14:31 ET

Goldman Sachs Maintains Warby Parker(WRBY.US) With Buy Rating, Cuts Target Price to $18

Moomoo NewsApr 22 14:31 ET

Warby Parker Is Maintained at Buy by Goldman Sachs

Dow JonesApr 22 11:07 ET

Warby Parker Price Target Cut to $18.00/Share From $29.00 by Goldman Sachs

Dow JonesApr 22 11:07 ET

Warby Parker Analyst Ratings

BenzingaApr 22 10:58 ET

Loop Capital Upgrades Warby Parker(WRBY.US) to Buy Rating, Maintains Target Price $27

Moomoo NewsApr 17 14:31 ET

Loop Capital Upgrades Warby Parker to Buy, Announces $27 Price Target

BenzingaApr 17 07:17 ET

Baird Maintains Warby Parker(WRBY.US) With Buy Rating, Cuts Target Price to $24

Moomoo NewsApr 14 14:31 ET

Piper Sandler Maintains Warby Parker(WRBY.US) With Buy Rating, Cuts Target Price to $20

Moomoo NewsApr 11 14:31 ET

Stifel Maintains Warby Parker(WRBY.US) With Hold Rating, Cuts Target Price to $18

Moomoo NewsApr 10 14:31 ET

Warby Parker Is Maintained at Hold by Stifel

Dow JonesApr 10 10:39 ET

Warby Parker Analyst Ratings

BenzingaApr 10 10:29 ET

BTIG Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsMar 31 14:31 ET

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Warby Parker (WRBY) and 89bio (ETNB)

TipRanksMar 3 04:23 ET

A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $25 to $32

Moomoo NewsMar 1 08:01 ET

Warby Parker Analyst Ratings

BenzingaFeb 28 16:54 ET

Warby Parker Is Maintained at Neutral by UBS

Dow JonesFeb 28 14:06 ET

Warby Parker (WRBY) Receives a Hold From Morgan Stanley

TipRanksFeb 28 09:14 ET